US Patent 11058668 Methods of treating TTR amyloidosis using AG10
Patent 11058668 was granted and assigned to Eidos Therapeutics on July, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 22, 2019
Date of Patent
July 13, 2021
Patent Applicant
Patent Application Number
16361587
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11058668 Methods of treating TTR amyloidosis using AG10
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.